Disease Overview：Chronic Kidney Disease（CKD）
Chronic Kidney Disease (CKD) is a progressive, irreversible decline in glomerular filtration rate (GFR) lasting ≥3 months, classified into five stages based on GFR and albuminuria levels. It commonly arises from diabetes mellitus, hypertension, glomerulonephritis, or polycystic kidney disease, and may advance to end-stage renal disease (ESRD), necessitating dialysis or kidney transplantation. Early detection—via serum creatinine, estimated GFR (eGFR), urinary albumin-to-creatinine ratio (UACR), and renal ultrasound—is critical to slow progression through blood pressure control, RAAS inhibition, glycemic management, and lifestyle intervention. Without timely intervention, CKD increases cardiovascular morbidity and mortality significantly.
China offers compelling advantages for international patients seeking CKD management. Its nephrology centers—many affiliated with top-tier academic hospitals—boast internationally trained specialists, advanced diagnostic capabilities (including multiparametric MRI, next-generation sequencing for genetic kidney disorders, and real-time eGFR monitoring platforms), and high-volume experience in complex cases, including diabetic nephropathy and transplant immunosuppression protocols. Success rates for preemptive transplantation and peritoneal dialysis initiation align closely with global benchmarks, while treatment costs remain 40–60% lower than in the US, UK, or Germany—without compromising clinical rigor or regulatory compliance. As a dedicated medical tourism agency, we facilitate seamless access: vetting JCI-accredited or NMPA-certified hospitals, coordinating specialist consultations, clarifying all-inclusive pricing upfront, arranging visas and accommodation, and providing bilingual clinical liaison and post-treatment follow-up support—ensuring continuity of care across borders.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Chronic Kidney Disease (Nephrology)
Non-Surgical / Conservative Management
*Target Criteria:* CKD Stages 1–4, eGFR ≥15 mL/min/1.73m², stable proteinuria, no acute decompensation.
- •Core Medication Regimen (Monthly):
- SGLT2 inhibitor (e.g., dapagliflozin 10 mg): $22–$35 - Phosphate binder (sevelamer 800 mg × 3/day): $18–$26 - Erythropoiesis-stimulating agent (epoetin beta, if Hb <10 g/dL): $45–$72
- •Monitoring (Per Visit, Quarterly):
- Urine ACR (albumin-to-creatinine ratio): $9 - Hemoglobin + ferritin + TSAT: $16 - Renal ultrasound (annual): $28
Surgical / Procedural / Interventional Options
*Eligibility:* CKD Stage 5 (eGFR <15), dialysis-dependent or imminent failure; vascular access required for hemodialysis or transplant evaluation.
- •Arteriovenous Fistula (AVF) Creation:
- Procedure (surgery + anesthesia): $1,150–$1,480
- •Peritoneal Dialysis Catheter Insertion (Laparoscopic):
- Procedure + catheter kit: $1,320–$1,650
- •Kidney Transplant Evaluation (Pre-transplant workup only):
- •Deceased Donor Kidney Transplant (Surgery + 30-day inpatient care):
Special / Complex Condition Management
- •CKD with Rapid Progression (eGFR decline >5 mL/min/year):
- •Dialysis-Related Amyloidosis or Refractory Hyperparathyroidism:
- •CKD-MBD with Severe Vascular Calcification:
Quick Selection Guide
- •Age <50, eGFR 30–45, no diabetes/hypertension: Prioritize conservative management ($120–$180/month); avoid early AVF.
- •Age 55–70, eGFR <15, comorbid CAD/diabetes: Initiate AVF creation now ($1,150–$1,480) — avoids catheter complications.
- •Age <40, family history of ESRD, eGFR 25–35: Fast-track transplant evaluation ($1,890–$2,360); preemptive transplant yields best 10-year survival.
- •Budget-constrained (≤$200/month), eGFR 15–29: Start low-cost conservative care (ACEi + dietary counseling); defer SGLT2i until subsidy available.
- •Frail elderly (>75), multiple comorbidities, eGFR <10: Opt for palliative nephrology + home-based peritoneal dialysis ($1,320–$1,650 setup + $320/month supplies).
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Chronic Kidney Disease Medical Vacation Packages
Curated transparent all-inclusive packages combining Chronic Kidney Disease treatment with China top medical destinations:
